Vivoryon Therapeutics’ glutaminyl cyclase inhibitor has failed a second phase 2 Alzheimer’s disease study this year, leaving the German biotech trying to find a silver lining in the drug’s potential ...
AnaptysBio has abandoned plans to develop rosnilimab for ulcerative colitis (UC) after the PD-1 agonist flunked a phase 2 study. The San Diego-based biopharma assessed rosnilimab in the midstage study ...
Critical violations: Raw eggs and raw meat stored above ready-to-eat foods in walk-in cooler (corrected - raw eggs and meat moved to the bottom shelf to avoid cross contamination). Spray bottle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results